Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 37 - Drugs for immunological or allergic disorders
Patents for A61P 37 - Drugs for immunological or allergic disorders (117,141)
10/1996
10/08/1996US5563048 Human stromal derived factor 1α and 1β, and DNAs encoding the same
10/08/1996CA1338632C Cloning and sequencing of the gene which codes for a new pilinic subunit of bordetella pertussis
10/03/1996WO1996030539A1 Engineered acarid allergen and process for producing the same
10/03/1996WO1996030533A1 Pseudotyped retroviral particles
10/03/1996WO1996030527A1 Mutated proteins coded by a lentivirus mutated env gene, peptide fragments and expression vectors
10/03/1996WO1996030406A1 Human g-protein coupled receptors
10/03/1996WO1996030397A1 New peptides with immunomodulatory effects
10/03/1996WO1996030332A1 O-malonyltyrosyl compounds, o-malonyltyrosyl compound-containing peptides, and uses thereof
10/03/1996WO1996030057A1 Synthetic peptides and pharmaceutical compositions comprising them for the treatment of systemic lupus erythematosus
10/03/1996WO1996030042A2 Methods of treating inflammation and compositions therefor
10/03/1996WO1996030035A1 β-SHEET MIMETICS AND USE THEREOF AS INHIBITORS OF BIOLOGICALLY ACTIVE PEPTIDES OR PROTEINS
10/03/1996WO1996030025A1 Synergistic combinations of zidovudine, 1592u89 and 3tc or ftc
10/03/1996WO1996030007A1 Mercapto and seleno derivatives as inhibitors of nitric oxide synthase
10/03/1996WO1996026285A3 Methods and compositions for administering gene therapy vectors
10/03/1996WO1996022373A3 Monoclonal antibody 1a7 and use for the treatment of melanoma and small cell carcinoma
10/03/1996CA2770491A1 Hapten-carrier conjegates for use in drug-abuse therapy
10/03/1996CA2216612A1 Mutated proteins coded by a lentivirus mutated env gene, peptide fragments and expression vectors
10/03/1996CA2215720A1 .beta.-sheet mimetics and use thereof as inhibitors of biologically active peptides or proteins
10/03/1996CA2214988A1 Method of treating inflammation and compositions therefor
10/03/1996CA2189656A1 New peptides with immunomodulatory effects
10/02/1996EP0735019A2 Retroviral protease inhibitors
10/02/1996EP0734725A2 Adjuvants containing colloidal iron compounds
10/02/1996EP0734389A1 Rapamycin derivatives useful as immunosuppressants
10/02/1996EP0734388A1 IMPROVED PROCESS FOR THE SYNTHESIS OF 2-AMINO-3,5-DIHYDRO-7-SUBSTITUTED-4H-PYRROLO[3,2-d]PYRIMIDIN-4-ONES
10/02/1996EP0734387A1 Hiv protease inhibitors
10/02/1996EP0734386A1 Platelet activating factor antagonists: imidazopyridine indoles
10/02/1996EP0734381A1 Morpholine and thiomorpholine tachykinin receptor antagonists
10/02/1996EP0734376A1 Vitamin d amine and amide derivatives
10/02/1996EP0734251A1 Method of transmitting a biologically active material to a cell
10/02/1996EP0597850B1 Crystalline interleukin-4
10/02/1996CN1132512A C-22 ring stabilized rapamycin derivatives
10/02/1996CN1132510A Hydroisoquinoline derivatives
10/02/1996CN1132479A Mycophenolate mofetil high dose oral suspensions
10/02/1996CN1132210A Cyclohexapeptides and their mixtures, process for preparing them, and their use
10/01/1996US5561228 Immunosuppressnats; side effect reduction
10/01/1996US5561140 Substituted alicyclic amine-containing macrocyclic immunomodulators
10/01/1996US5561117 Bridged bis-aryl carbinol derivatives, compositions and methods of use
10/01/1996US5561113 Analgesics; antiiflammatory agents; gastrointestinal, urogenital and nervous system(cns) disorders; asthma; antiallergens
10/01/1996US5560935 Administering to inhibit plasma kallikrein production: improves peripheral blood flow, exhibits analgesic, antiinflammatory and antiallergic properties
10/01/1996US5560914 Immunopotentiator and method of manufacturing the same
10/01/1996CA1338625C Tricyclic compounds
10/01/1996CA1338618C Vaccine adjuvant
09/1996
09/28/1996CA2172685A1 Adjuvant based on colloidal iron compounds
09/26/1996WO1996029425A1 Hormone and growth factor phosphoglycan mimetics from mycobacterium vaccae
09/26/1996WO1996029421A1 Vectors for gene delivery
09/26/1996WO1996029411A1 Protein production and delivery
09/26/1996WO1996029408A1 Il-17 receptor
09/26/1996WO1996029341A1 Human stat4
09/26/1996WO1996029339A1 Fucopeptides
09/26/1996WO1996029336A1 Chemical compounds
09/26/1996WO1996029333A1 Substituted tetronic acids useful for treating hiv and other retroviruses
09/26/1996WO1996029315A2 Imidazole derivatives as histamine receptor h3 (ant)agonists
09/26/1996WO1996029304A1 Nonpeptides as tachykinin antagonists
09/26/1996WO1996029077A1 Use of thiazepine, oxazepine and diazepine coumpounds for inhibiting hiv, herpesvirus and suppressing the immune system
09/26/1996WO1996029056A1 Topically applied pharmaceutical composition, method of preparing it and its use
09/26/1996WO1996023071A3 MONOCLONAL ANTIBODIES SPECIFIC FOR DIFFERENT EPITOPES OF HUMAN gp39 AND METHODS FOR THEIR USE IN DIAGNOSIS AND THERAPY
09/26/1996CA2215618A1 Protein production and delivery
09/26/1996CA2215162A1 Vectors for gene delivery
09/26/1996CA2214107A1 Fucopeptides
09/26/1996CA2211191A1 Nonpeptides as tachykinin antagonists
09/26/1996CA2211179A1 Use of thiazepine, oxazepine and diazepine coumpounds for inhibiting hiv, herpesvirus and suppressing the immune system
09/26/1996CA2190865A1 Imidazole derivatives as histamine receptor h3 (ant)agonists
09/25/1996EP0733647A2 Polysaccharides and preparation thereof
09/25/1996EP0733373A2 Compositions and methods for increasing the immunogenicity of tumor cells by administration of B7 and CD2-transfected cells
09/25/1996EP0733107A1 C5a RECEPTOR ANTAGONISTS HAVING SUBSTANTIALLY NO AGONIST ACTIVITY
09/25/1996EP0733071A1 Antagonists to chaperonin 10
09/25/1996EP0733067A1 N-terminally chemically modified protein compositions and methods
09/25/1996EP0733066A1 Pretargeting methods and compounds
09/25/1996EP0733065A1 Novel peptides derived from autoantigen for use in immunotherapy of autoimmune diseases
09/25/1996EP0733064A1 NUCLEIC ACIDS ENCODING A HOUSE DUST MITE ALLERGEN, $i(DER P) III, AND USES THEREFOR
09/25/1996EP0733053A1 Oxathiolanes, method for their preparation and pharmaceutical compositions containing same
09/25/1996EP0733049A1 Tricyclic derivatives and their use in pharmaceuticals
09/25/1996EP0733047A1 Novel substituted oxazolidines
09/25/1996EP0733043A1 Tricyclic derivatives and their use in pharmaceuticals
09/25/1996EP0733041A1 Anthracene spiro-pyrrolidines as immuno-modulators
09/25/1996EP0733040A1 Piperazine-substituted pyrroloanthracene as immuno-moderators
09/25/1996EP0733039A1 Substituted pyrroloanthracenes and pyrroloanthracene diones as immunomodulators
09/25/1996EP0733035A1 Tricyclic derivatives, pharmaceutical compositions containing them
09/25/1996EP0732938A1 Method of treating intestinal disorders
09/25/1996EP0732930A1 Compositions which inhibit apoptosis, methods of purifying the compositions and uses thereof
09/25/1996EP0732929A1 Therapeutic use of cis-element decoys in vivo
09/25/1996EP0674513B1 Retroviral protease inhibiting compounds
09/25/1996EP0511308B1 Chimeric immunoglobulin for cd4 receptors
09/25/1996EP0432249B1 Monoclonal antibodies against leukocyte adhesion receptor beta-chain, methods of producing these antibodies and use therefore
09/25/1996EP0423221B1 Immunosuppressive agents
09/25/1996CN1131563A Glossy ganoderma pill
09/24/1996US5559256 Aminediol protease inhibitors
09/24/1996US5559213 Polyethylene-protein conjugates
09/24/1996US5559211 Biologically active product produced by streptococcus pyogenes and method of purification
09/24/1996US5559148 Parenteral busulfan for treatment of malignant disease
09/24/1996US5559123 Derivatives of benzoylecgonine, ecgonine and ecgonidine and methods for preparing and using same
09/24/1996US5559122 Hindered N-oxide esters of rapamycin
09/24/1996US5559121 Rapamycin formulations for oral administration
09/24/1996US5559113 Imidazole compounds and their therapeutic applications
09/24/1996US5559028 Methods of enhancing or antigen presentation to T cells inhibiting
09/24/1996US5559012 Monoclonal antibodies detected with cytokines and kits
09/24/1996CA2172436A1 Compositions and methods for increasing the immunogenicity of tumor cells
09/19/1996WO1996028183A1 Method for treatment of autoimmune diseases using interferon-tau
09/19/1996WO1996028180A1 Method of manufacturing a therapeutic agent for the regeneration of oligodendrocytes
09/19/1996WO1996028175A1 Immunomodulating compositions from bile for the treatment of immune system disorders
1 ... 1046 1047 1048 1049 1050 1051 1052 1053 1054 1055 1056 1057 1058 1059 1060 1061 1062 1063 1064 1065 1066 ... 1172